...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Slide 6

I'm not sure I understand slide 6 from today's power point.  No key is provided and the scaling is not completely clear.

What is the takeaway?

Thanks in advance

 

Share
New Message
Please login to post a reply